| Name | HBV-IN-14 |
|---|---|
| Synonyms | Cyclobutanecboxylic acid, 3-[2-[4-(9-chloro-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)phenoxy]ethoxy]-1-methyl-, cis |
| Description | HBV-IN-14 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-14 is a pyridinopyrimidinones compound. HBV-IN-14 has the potential for the research of HBV infection (extracted from patent WO2021190502A1, compound 5)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Lifang Wu, et al. Pyridopyrimidinones. Patent WO2021190502A1. |
| Molecular Formula | C22H21ClN2O5 |
|---|---|
| Molecular Weight | 428.87 |